Skip to main content
Skip to primary sidebar
Search
Aphios
Inspired by Nature, Enabled by Science®
Products
▼
Enhanced Therapeutic Products Overview
Therapeutic Products Pipeline
▼
Oncology
▼
Zindol®
APH-0701
APH-0911
APH-0912
APH-0804
Taxosomes™
Camposomes™
Dermos™
APH-0201
Sperol™
Infectious Disease
▼
APH-0812
APH-0202
nanoHYP™
Asterias™
Marinus™
HIV/AIDS Therapeutic Vaccine
Anti-HIV Therapeutics
Anti-Influenza Therapeutics
Vaccine Adjuvant Technology
▼
Anthrax Vaccine Adjuvant
CNS Disorders
▼
APH-1104
Xantol™
APH-0802 – nanoTHC™
APH-1403
Diabetes
▼
APH-0907
Research Chemicals & API’s
▼
Adhyperforin
Adhyperforin DCHA
Betulin
Betulinic Acid
Bryostatin 1
Bryostatin 2
Bryostatin 3
Camptothecin
C-ATR
Cephalomannine
Cyclopamine
Cycloposine
10-DAB
9-DHAB
Δ9-THC
Δ9-THCA
Frondoside A
6-Gingerol
8-Gingerol
10-Gingerol
Hypericin
Hyperforin
Hyperforin DCHA
Jervine
MLA
Muldamine
Nobiletin
Paclitaxel
Phloridzin Dihydrate
Sclareolide
6-Shogaol
Tangeretin
Veratramine
Equipment
Quality of Life Medicines
Technology
▼
Enabling Technology Platforms
Drug Discovery
Drug Manufacturing
Drug Delivery
▼
CFN
PNS
PNP
Drug Safety
▼
CFI™ Mechanisms of Action & Applications
Microbial Cell Disruption
Crystallization
▼
Natural Therapeutics Crystallization – CRY
SuperFluids Crystallization Process
Biomass Pretreatment
▼
Cellulosic Biomass Pretreatment (CBP) – Aosic Platform
Partnering
▼
Partnering Overview
▼
Zindol LLC
Pharmaceutical & Biotechnology Partners
University Partners
Institutional Research Partners
Investors
▼
Investors Overview
▼
Aphios Pharma LLC
Aphios International LLC
Resources
▼
Resources Overview
Facilities
Intellectual Property
Marine Microorganism Library
Research Grants & Contracts
About
▼
Company Overview
Management & Directors
Scientific Advisory Board
Community Involvement
Press Releases
Events
Careers
Contact
Shop
Products
Enhanced Therapeutic Products Overview
Therapeutic Products Pipeline
Oncology
Zindol®
APH-0701
APH-0911
APH-0912
APH-0804
Taxosomes™
Camposomes™
Dermos™
APH-0201
Sperol™
Infectious Disease
APH-0812
APH-0202
nanoHYP™
Asterias™
Marinus™
HIV/AIDS Therapeutic Vaccine
Anti-HIV Therapeutics
Anti-Influenza Therapeutics
Vaccine Adjuvant Technology
Anthrax Vaccine Adjuvant
CNS Disorders
APH-1104
Xantol™
APH-0802 – nanoTHC™
APH-1403
Diabetes
APH-0907
Research Chemicals & API’s
Adhyperforin
Adhyperforin DCHA
Betulin
Betulinic Acid
Bryostatin 1
Bryostatin 2
Bryostatin 3
Camptothecin
C-ATR
Cephalomannine
Cyclopamine
Cycloposine
10-DAB
9-DHAB
Δ9-THC
Δ9-THCA
Frondoside A
6-Gingerol
8-Gingerol
10-Gingerol
Hypericin
Hyperforin
Hyperforin DCHA
Jervine
MLA
Muldamine
Nobiletin
Paclitaxel
Phloridzin Dihydrate
Sclareolide
6-Shogaol
Tangeretin
Veratramine
Equipment
Quality of Life Medicines
Technology
Enabling Technology Platforms
Drug Discovery
Drug Manufacturing
Drug Delivery
CFN
PNS
PNP
Drug Safety
CFI™ Mechanisms of Action & Applications
Microbial Cell Disruption
Crystallization
Natural Therapeutics Crystallization – CRY
SuperFluids Crystallization Process
Biomass Pretreatment
Cellulosic Biomass Pretreatment (CBP) – Aosic Platform
Partnering
Partnering Overview
Zindol LLC
Pharmaceutical & Biotechnology Partners
University Partners
Institutional Research Partners
Investors
Investors Overview
Aphios Pharma LLC
Aphios International LLC
Resources
Resources Overview
Facilities
Intellectual Property
Marine Microorganism Library
Research Grants & Contracts
About
Company Overview
Management & Directors
Scientific Advisory Board
Community Involvement
Press Releases
Events
Careers
Contact
Shop
Aphios Awarded NIH SBIR Grant For Development of Anti-CCR5 Nanoparticles to Treat Alzheimer’s Disease
In-Part_AD_Amyloid_Plaques_0724
